3,3'-diindolylmethane and Neoplasm Metastasis
3,3'-diindolylmethane has been researched along with Neoplasm Metastasis in 5 studies
3,3'-diindolylmethane: anti-inflammatory from edible cruciferous vegetables; a cytochrome P-450 antagonist
Neoplasm Metastasis: The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"In vivo study showed the metastasis was significantly reduced." | 5.43 | ERK signaling mediates long-term low concentration 3,3'-diindolylmethane inhibited nasopharyngeal carcinoma growth and metastasis: An in vitro and in vivo study. ( Chen, C; Chen, SM; Li, F; Tao, ZZ; Xiao, BK, 2016) |
"The hallmarks of EMT in cancer cells include changed cell morphology and increased metastatic capabilities in cell migration and invasion." | 2.53 | Roles of Dietary Phytoestrogens on the Regulation of Epithelial-Mesenchymal Transition in Diverse Cancer Metastasis. ( Choi, KC; Hwang, KA; Lee, GA, 2016) |
"Ovarian cancer is a highly lethal gynecological malignancy for which the overall prognosis has remained poor over the past few decades." | 1.43 | IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in ovarian cancer cells. ( Xu, C; Zhang, X; Zou, M, 2016) |
"In vivo study showed the metastasis was significantly reduced." | 1.43 | ERK signaling mediates long-term low concentration 3,3'-diindolylmethane inhibited nasopharyngeal carcinoma growth and metastasis: An in vitro and in vivo study. ( Chen, C; Chen, SM; Li, F; Tao, ZZ; Xiao, BK, 2016) |
"Current treatments for thyroid cancer, such as surgery or radioactive iodine therapy, often require patients to be on lifelong thyroid hormone replacement therapy and given the significant recurrence rates of thyroid cancer, new preventive modalities are needed." | 1.37 | Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in thyroid cancer. ( Geliebter, J; George, A; Rajoria, S; Schantz, SP; Shanmugam, A; Suriano, R; Tiwari, RK, 2011) |
Research
Studies (5)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Zou, M | 1 |
Zhang, X | 1 |
Xu, C | 1 |
Li, F | 1 |
Chen, C | 1 |
Chen, SM | 1 |
Xiao, BK | 1 |
Tao, ZZ | 1 |
Lee, GA | 1 |
Hwang, KA | 1 |
Choi, KC | 1 |
Rahman, KM | 1 |
Banerjee, S | 1 |
Ali, S | 1 |
Ahmad, A | 1 |
Wang, Z | 1 |
Kong, D | 1 |
Sakr, WA | 1 |
Rajoria, S | 1 |
Suriano, R | 1 |
George, A | 1 |
Shanmugam, A | 1 |
Schantz, SP | 1 |
Geliebter, J | 1 |
Tiwari, RK | 1 |
Reviews
1 review available for 3,3'-diindolylmethane and Neoplasm Metastasis
Article | Year |
---|---|
Roles of Dietary Phytoestrogens on the Regulation of Epithelial-Mesenchymal Transition in Diverse Cancer Metastasis.
Topics: Anticarcinogenic Agents; Antineoplastic Agents; Cell Line, Tumor; Epithelial-Mesenchymal Transition; | 2016 |
Other Studies
4 other studies available for 3,3'-diindolylmethane and Neoplasm Metastasis
Article | Year |
---|---|
IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in ovarian cancer cells.
Topics: Blotting, Western; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival | 2016 |
ERK signaling mediates long-term low concentration 3,3'-diindolylmethane inhibited nasopharyngeal carcinoma growth and metastasis: An in vitro and in vivo study.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Cadherins; Carcinoma; | 2016 |
3,3'-Diindolylmethane enhances taxotere-induced apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Breast Neoplasms; Cell Division; Cell Lin | 2009 |
Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in thyroid cancer.
Topics: Anticarcinogenic Agents; Cell Adhesion; Cell Line, Tumor; Cell Movement; Estrogen Receptor alpha; Es | 2011 |